UniProt Q9BYT3 · PDB · AlphaFold · Substrate: MBP · Clone: full length
Top inhibitors
| # | Drug | Inhibition | Residual | KISS | Gini |
|---|---|---|---|---|---|
| 1 | Bosutinib | 83.0% | 17.0% | 87.22 | 0.555 |
| 2 | Brigatinib | 79.8% | 20.2% | 82.96 | 0.513 |
| 3 | Sunitinib | 79.7% | 20.3% | 91.73 | 0.524 |
| 4 | Defactinib | 78.1% | 21.9% | 92.68 | 0.450 |
| 5 | Abemaciclib | 75.5% | 24.5% | 91.48 | 0.563 |
| 6 | Midostaurin | 74.7% | 25.3% | 78.64 | 0.500 |
| 7 | Pacritinib | 72.4% | 27.6% | 88.64 | 0.452 |
| 8 | Alectinib | 71.7% | 28.3% | 95.49 | 0.651 |
| 9 | Gilteritinib | 66.4% | 33.6% | 88.97 | 0.506 |
| 10 | Ceritinib | 66.4% | 33.6% | 95.44 | 0.618 |
| 11 | Netarsudil | 61.6% | 38.4% | 93.22 | 0.676 |
| 12 | Fedratinib | 49.4% | 50.6% | 96.21 | 0.576 |
| 13 | Osimertinib | 48.0% | 52.0% | 97.24 | 0.733 |
| 14 | Neratinib | 48.0% | 52.0% | 93.18 | 0.597 |
| 15 | Capivasertib | 46.9% | 53.1% | 96.48 | 0.644 |
| 16 | Palbociclib | 42.1% | 57.9% | 98.75 | 0.673 |
| 17 | Ponatinib | 40.1% | 59.9% | 78.23 | 0.534 |
| 18 | Fostamatinib | 37.8% | 62.2% | 96.74 | 0.613 |
| 19 | Nintedanib | 35.4% | 64.6% | 90.23 | 0.608 |
| 20 | Avapritinib | 33.0% | 67.0% | 97.73 | 0.644 |
Paralog block
No paralog group registered for this kinase.
EMT expression
- Mesenchymal log2(TPM+1): 1.77
- Epithelial log2(TPM+1): 1.26
- Fold change: 0.50
- Status: No significant change
Selectivity landscape vs inhibition on STK33
Each point is one of the 92 approved drugs; color = inhibition % on STK33.
3D structure
Embedded NGL viewer pulls a representative PDB entry (or AlphaFold model if no experimental structure is registered). Heavy bundle — loaded only on demand.
Annotations
Sign in to read and post annotations.
Loading…